Intco Medical Technology Management
Management criteria checks 3/4
Intco Medical Technology's CEO is Qiong Chen, appointed in Jan 2015, has a tenure of 10.25 years. directly owns 0.067% of the company’s shares, worth CN¥9.33M. The average tenure of the management team and the board of directors is 6.5 years and 4.8 years respectively.
Key information
Qiong Chen
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 10.3yrs |
| CEO ownership | 0.07% |
| Management average tenure | 6.5yrs |
| Board average tenure | 4.8yrs |
Recent management updates
Recent updates
Intco Medical Technology (SZSE:300677) Might Be Having Difficulty Using Its Capital Effectively
Mar 14
Fewer Investors Than Expected Jumping On Intco Medical Technology Co., Ltd. (SZSE:300677)
Feb 27Is Intco Medical Technology Co., Ltd. (SZSE:300677) Potentially Undervalued?
Jan 05Intco Medical Technology (SZSE:300677) Seems To Use Debt Quite Sensibly
Nov 25There May Be Underlying Issues With The Quality Of Intco Medical Technology's (SZSE:300677) Earnings
Nov 04Intco Medical Technology (SZSE:300677) Seems To Use Debt Quite Sensibly
Aug 19Intco Medical Technology Co., Ltd. (SZSE:300677) Looks Inexpensive But Perhaps Not Attractive Enough
Jul 15Capital Allocation Trends At Intco Medical Technology (SZSE:300677) Aren't Ideal
May 21Intco Medical Technology (SZSE:300677) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of
May 02Intco Medical Technology Co., Ltd.'s (SZSE:300677) Business Is Trailing The Market But Its Shares Aren't
Mar 28CEO
Qiong Chen (42 yo)
10.3yrs
Tenure
CN¥1,946,000
Compensation
Ms. Chen Qiong serves as General Manager and Director of Intco Medical Technology Co., Ltd. (formerly known as Shandong Intco Medical Products Co., Ltd.) Since January 2015, Ms. Chen has served in Intco Me...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| GM & Director | 10.3yrs | CN¥1.95m | 0.067% CN¥ 9.3m | |
| Financial Director | 6.5yrs | CN¥743.20k | 0.042% CN¥ 5.9m | |
| Secretary of the Board & Deputy GM | 6.5yrs | CN¥928.10k | no data | |
| Deputy GM & Non-Independent Director | no data | CN¥1.41m | 0.036% CN¥ 5.1m | |
| Chairman of the Board of Supervisors | no data | no data | no data |
6.5yrs
Average Tenure
41yo
Average Age
Experienced Management: 300677's management team is seasoned and experienced (6.5 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| GM & Director | 10.3yrs | CN¥1.95m | 0.067% CN¥ 9.3m | |
| Deputy GM & Non-Independent Director | 6.5yrs | CN¥1.41m | 0.036% CN¥ 5.1m | |
| Chairman of the Board of Supervisors | 15yrs | no data | no data | |
| Chairman of the Board | 10yrs | CN¥3.20m | 36.11% CN¥ 5.0b | |
| Non-Independent Director | 10yrs | CN¥1.31m | no data | |
| Independent Director | 3.1yrs | CN¥134.00k | no data | |
| Independent Director | 3.1yrs | CN¥134.00k | no data | |
| Employee Supervisor | 3.1yrs | no data | 0.0011% CN¥ 159.3k | |
| Non-Employee Supervisor | no data | no data | no data | |
| Independent Director | no data | no data | no data |
4.8yrs
Average Tenure
48yo
Average Age
Experienced Board: 300677's board of directors are considered experienced (4.8 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/04/13 05:26 |
| End of Day Share Price | 2025/04/11 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Intco Medical Technology Co., Ltd. is covered by 5 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Yi Liu | Citic Securities Co., Ltd. |
| Xiao Wei Lin | Everbright Securities Co. Ltd. |
| Lingfei Kong | Huatai Research |